跳至主要内容
临床试验/NCT02425774
NCT02425774已完成4 期

Anti-inflammatory Effect of Pre-operative Stimulation of the Cholinergic Anti-Inflammatory Pathway: A Potential New Therapeutical Intervention for Postoperative Ileus

KU Leuven1 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2014年7月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
KU Leuven
入组人数
31
试验地点
1
主要终点
Levels of pro-inflammatory cytokines in intestinal tissue, serum, peritoneal lavage and supernatant of stimulated whole blood

研究概览

简要总结

Hypothesis:

Prucalopride can mimic electrical stimulation of the abdominal vagus nerve and has an anti-inflammatory effect.

Aims:

In the present pilot study, the investigators want to evaluate the anti-inflammatory effect of prucalopride. The following aims are formulated:

  1. to show that prucalopride has a similar inflammatory effect as abdominal vagus nerve stimulation (VNS)
  2. to evaluate whether prucalopride leads to accelerated post-operative recovery

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients undergoing partial or full resection of the pancreas due to a benign or malignant tumor

排除标准

  • adjuvant radiotherapy
  • evident intra-abdominal inflammation (diagnosed by imaging and/or laboratory results, including an abscess or cholecystitis)
  • chronic pancreatitis
  • pancreatic polypeptide producing endocrine tumor
  • American Society of Anesthesiologists physical-health status classification (ASA-PS)>3
  • Poorly regulated diabetes (>200 mg/dl (=11 mmol/l))

研究组 & 干预措施

Sham stimulation + Placebo

Placebo Comparator
  • no stimulation
  • 1 placebo tablet at two different timepoints before surgery

干预措施: Sham stimulation (Procedure)

Sham stimulation + Placebo

Placebo Comparator
  • no stimulation
  • 1 placebo tablet at two different timepoints before surgery

干预措施: Placebo (Drug)

Vagus stimulation + placebo

Active Comparator
  • Stimulation at the beginning and the end of the surgery
  • 1 placebo tablet at two different timepoints before surgery

干预措施: Vagus stimulation (Procedure)

Vagus stimulation + placebo

Active Comparator
  • Stimulation at the beginning and the end of the surgery
  • 1 placebo tablet at two different timepoints before surgery

干预措施: Placebo (Drug)

Prucalopride + sham stimulation

Active Comparator
  • 1 prucalopride tablet at two different timepoints before surgery
  • no stimulation

干预措施: Sham stimulation (Procedure)

Prucalopride + sham stimulation

Active Comparator
  • 1 prucalopride tablet at two different timepoints before surgery
  • no stimulation

干预措施: Prucalopride (Drug)

结局指标

主要结局

Levels of pro-inflammatory cytokines in intestinal tissue, serum, peritoneal lavage and supernatant of stimulated whole blood

时间窗: From the date of surgery until the date of lab analysis (up to 6 months)

次要结局

  • Time to first flatus(From the date of surgery until the date of discharge from the hospital (on average 14 days))
  • Time to tolerance of oral food intake AND first defecation(From the date of surgery until the date of discharge from the hospital (on average 14 days))
  • Time to first defecation(From the date of surgery until the date of discharge from the hospital (on average 14 days))
  • Time to discharge from the hospital(From the date of surgery until the date of discharge from the hospital (on average 14 days))
  • Time to tolerance of oral food intake(From the date of surgery until the date of discharge from the hospital (on average 14 days))
  • Gastrointestinal symptoms (nausea, pain, vomiting, bloating)(From the date of surgery until the date of discharge from the hospital (on average 14 days))

研究者

发起方
KU Leuven
申办方类型
Other
责任方
Principal Investigator
主要研究者

Guy Boeckxstaens

Principal Investigator

KU Leuven

研究点 (1)

Loading locations...

相似试验